KRASG12V Degraders Provide a Potential Therapeutic Opportunity in Lung Adenocarcinoma
{{output}}
Mutant KRAS inhibition has revolutionized the treatment of lung adenocarcinoma. Unfortunately, responses to this form of targeted therapy are often of limited duration because of the development of resistance. Targeted protein degradation, including using PROT... ...